Board of Directors
Lee A. Henderson, Ph.D.
Mr. Bartels is an active private investor in both early stage and listed biotech companies. He is the founder and President of Paxton Properties Incorporated, a real estate investment firm based in New York City that concentrates on acquiring and managing center city office buildings in the United States and Europe. Mr. Bartels is a director of several other private companies. Earlier in his career Mr. Bartels was an investment banker at Morgan Stanley & Co. Incorporated, New York and Tokyo, and Citicorp, New York. Mr. Bartels holds an A.B., from Harvard College and an M.B.A., from the Harvard Business School.
Nitin Parekh, Ph.D.
Dr. Parekh has worked at the management level for DSM, Chemie Linz, Upjohn (Pharmacia-Pfizer), Monsanto (The NutraSweet company), Hoechst, Boehringer Mannheim and Knoll AG. In addition, he has extensive experience in strategic development working with Biotech, Start-up and emerging pharma companies. Some of the companies Nitin has concluded deals with include Genzyme, Cubist, Myriad, Gilead, Ilex, and OSI Pharma.
An engineer by training, Mr. Schneider has over 35 years of corporate management experience at senior levels at companies that include C.R. Bard, Concord Laboratories, BIW cable where he led a successful IPO and Delta Cooling Towers which he brought back to profitability and successfully sold at a profit to stockholders. He was President of a Business Innovation Center and is currently a lecturer in Entrepreneurship at Cornell University. Mr. Schneider was a Naval Lieutenant in the submarine service.